On the Use of HIS Administrative Data to Assess Mortality Among Comorbid Hospitalized Patients – Lessons Learned from the COVID-19 Pandemic.

Publication date: Jun 26, 2025

COVID-19 was associated with hospitalization and high mortality rate. Previous studies suggested higher mortality rate in COVID-19 patients with comorbidities. To our knowledge, most of the published articles focused on clinical characteristics and treatment based on patients’ medical records (EMR). Based on our experience with comorbid hospitalized COVID-19 patients, we argue that HIS administrative data can be used to identify what comorbidities and other factors are associated with hospitalized COVID-19 patients’ mortality and provide a quick initial assessment in view to identifying comorbid individuals that are more prone to worse outcome thus improving patient management not only during pandemics.

Open Access PDF

Concepts	Keywords
Covid	Comorbidity
High	comorbidity
Hospitalization	COVID-19
Pandemic	COVID-19 pandemic
	Electronic Health Records
	HIS
	HIS administrative data
	Hospital Mortality
	Hospitalization
	Humans
	Male
	Pandemics
	SARS-CoV-2

Semantics

Type	Source	Name
disease	MESH	COVID-19 Pandemic
disease	MESH	comorbidity
disease	MESH	death
disease	MESH	cardiovascular diseases
disease	MESH	hypertension
disease	MESH	fatal outcomes
disease	MESH	morbidity
disease	MESH	parasitic diseases
disease	MESH	Malignant neoplasms
disease	MESH	metabolic diseases
disease	MESH	sepsis
disease	MESH	Cerebrovascular diseases
disease	MESH	heart failure
disease	MESH	chronic kidney disease
disease	MESH	end stage renal disease
disease	MESH	Cerebral infarction
disease	MESH	Acute respiratory distress syndrome
disease	MESH	respiratory failure
disease	MESH	Acute kidney failure
disease	MESH	diabetes mellitus
disease	MESH	complications
disease	MESH	Overweight
disease	MESH	obesity
disease	IDO	organism
disease	MESH	renal failure
disease	MESH	stroke
drug	DRUGBANK	Guanosine

Original Article

(Visited 9 times, 1 visits today)